Evidence map›Paper›PMID 39482913›Full record

ReviewCurrent medicinal chemistry2025

Developing Generalizable Scoring Functions for Molecular Docking: Challenges and Perspectives.

Rodrigo Quiroga, Marcos Ariel Villarreal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rodrigo QuirogaDepartamento de Química Teórica y Computacional, Facultad de Ciencias Químicas, Instituto de Investigaciones en Físico-Química de Córdoba, Universidad Nacional de Córdoba, INFIQC-CONICET, Cordoba, Argentina.ORCID 0000-0001-5015-0531
Marcos Ariel VillarrealDepartamento de Química Teórica y Computacional, Facultad de Ciencias Químicas, Instituto de Investigaciones en Físico-Química de Córdoba, Universidad Nacional de Córdoba, INFIQC-CONICET, Cordoba, Argentina.

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (Agencia I+D+i) PICT2019-2019-01979
6 · The paper itself

Abstract

Structure-based drug discovery methods, such as molecular docking and virtual screening, have become invaluable tools in developing novel drugs. At the core of these methods are Scoring Functions (SFs), which predict the binding affinity between ligands and protein targets. This study aims to review and contextualize the challenges and best practices in training novel scoring functions to improve their accuracy and generalizability in predicting protein-ligand binding affinities. Effective training of scoring functions requires careful attention to the quality of training data and methodologies. We emphasize the need for robust training strategies to produce consistent and generalizable SFs. Key considerations include addressing hidden biases and overfitting in machine-learning models, as well as ensuring the use of high-quality, unbiased datasets for both training and evaluation of SFs. Innovative hybrid methods, combining the advantages of empirical and machine-learning approaches, hold promise for outperforming current scoring functions while displaying greater generalizability and versatility.

Indexed as

Drug DiscoveryMolecular Docking SimulationProteinsHumansLigandsMachine LearningLigandsProteinscomputational drug discoverydeep learning.machine learningMolecular dockingscoring functionvirtual screening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.